MARVELD2 and ocular hypertension: In a dexamethasone-induced murine model of ocular hypertension, an intracameral injection of siRNA against tricellulin led to reduced tricellulin and ZO-1 expression in Schlemm’s canal endothelial cells and reduced intraocular pressure [136].